Hepatitis B virus (HBV) infects more than 250 million people worldwide and can lead to chronic liver disease and liver cancer ...

Researchers at the Kanazawa University Graduate School of Medical Sciences report in PLOS Pathogens a novel role for the ...

The CDC's Advisory Committee on Immunization Practices (ACIP) has voted by 8 to 3 to remove the recommendation that all infants aged under two months receive a hepatitis B virus (HBV) vaccine, ...

The AUSHINE study is a randomized, double-blind, multicenter Phase III trial evaluating the efficacy and safety of AHB-137 injection in participants with HBeAg-negative CHB treated with nucleos (t)ide ...

The hepatitis B vaccine, which 'virtually eliminated' the disease in children, will no longer be given at birth unless parents request it, due to a new move from the CDC.

The Centers for Disease Control and Prevention made a major change to the childhood immunization schedule this week, ending a decades-old policy that supports giving all newborns a hepatitis B viru | ...

The Trump administration has awarded a $1.6 million, no-bid contract a Danish university to study hepatitis B vaccinations on ...

First CTA authorization marks nChroma's transition to a clinical-stage company; first patient dosing in Phase 1/2 trial planned for early 2026 Preclinical studies demonstrated CRMA-1001 delivers ...

On Dec. 5, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices voted to end the ...

The latest update is out from Biotron ( (AU:BIT) ).

Background Withdrawal of prolonged nucleos(t)ide analogue (NA) treatment results in hepatitis B surface antigen (HBsAg) loss in some subjects with chronic hepatitis B (CHB), potentially revealing ...